Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Colorcon
Cipla
Chubb
Harvard Business School
Healthtrust
Deloitte
Boehringer Ingelheim
Moodys

Generated: May 23, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: naproxen

« Back to Dashboard

naproxen

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Atnahs Pharma Us NAPROSYN naproxen SUSPENSION;ORAL 018965 NDA Key Therapeutics, LLC N 70868-200-16
Atnahs Pharma Us NAPROSYN naproxen SUSPENSION;ORAL 018965 NDA Athena Bioscience N 71511-701-16
West-ward Pharms Int NAPROXEN naproxen SUSPENSION;ORAL 074190 ANDA Palmetto Pharmaceuticals N 68134-201-16
Atnahs Pharma Us EC-NAPROSYN naproxen TABLET, DELAYED RELEASE;ORAL 020067 NDA Genentech, Inc. N 0004-6415-01
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
US Department of Justice
Mallinckrodt
Accenture
QuintilesIMS
Chubb
Healthtrust
Daiichi Sankyo
Cipla